Fabian Nietlispach
Trends in Coronary and Structural Heart Interventions in Switzerland over the Last 16 Years and Impact of COVID-19: Insights from the National Swiss PCI Survey.
Wagener M, Boeddinghaus J, Gaemperli O, Räber L, Nietlispach F, Meier P, Muller O, Weilenmann D, Jeger R. Trends in Coronary and Structural Heart Interventions in Switzerland over the Last 16 Years and Impact of COVID-19: Insights from the National Swiss PCI Survey. J Clin Med 2022; 11
15.12.2022Trends in Coronary and Structural Heart Interventions in Switzerland over the Last 16 Years and Impact of COVID-19: Insights from the National Swiss PCI Survey.
15.12.2022J Clin Med 2022; 11
Wagener Max, Boeddinghaus Jasper, Gaemperli Oliver, Räber Lorenz, Nietlispach Fabian, Meier Pascal, Muller Olivier, Weilenmann Daniel, Jeger Raban
Coronary and structural heart interventions in Switzerland 2019
Wagener M, Jeger R, Weilenmann D, Räber L, Nietlispach F, Muller O, Meier P, Gämperli O, Cook S, Twerenbold R, On Behalf Of The Swiss Working Group Interventional Cardiology Of The Swiss Society Of Cardiology. Coronary and structural heart interventions in Switzerland 2019. Swiss Med Wkly 2021; 151:w20495.
11.05.2021Coronary and structural heart interventions in Switzerland 2019
11.05.2021Swiss Med Wkly 2021; 151:w20495
Wagener Max, Jeger Raban, Weilenmann Daniel, Räber Lorenz, Nietlispach Fabian, Muller Olivier, Meier Pascal, Gämperli Oliver, Cook Stéphane, Twerenbold Raphael, On Behalf Of The Swiss Working Group Interventional Cardiology Of The Swiss Society Of Cardiology
Feasibility and safety of transfemoral sheathless portico aortic valve implantation: Preliminary results in a single center experience
Taramasso M, Nietlispach F, Kottwitz J, Rodriguez Cetina Biefer H, Sütsch G, Haager P, Rickli H, Kuwata S, Denegri A, Maisano F. Feasibility and safety of transfemoral sheathless portico aortic valve implantation: Preliminary results in a single center experience. Catheter Cardiovasc Interv 2017; 91:533-539.
13.05.2017Feasibility and safety of transfemoral sheathless portico aortic valve implantation: Preliminary results in a single center experience
13.05.2017Catheter Cardiovasc Interv 2017; 91:533-539
Taramasso Maurizio, Nietlispach Fabian, Kottwitz Jan, Rodriguez Cetina Biefer Hector, Sütsch Gabor, Haager Philipp K., Rickli Hans, Kuwata Shingo, Denegri Andrea, Maisano Francesco
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction
Pilgrim T, Jüni P, Wenaweser P, Blöchlinger S, Nietlispach F, Rigamonti F, Taniwaki M, Khattab A, Jamshidi P, Kaiser C, Weilenmann D, Cook S, Muller O, Vuilliomenet A, Tüller D, Roffi M, Heg D, Piccolo R, Windecker S. Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction. EuroIntervention 2015; 11
23.12.2015Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction
23.12.2015EuroIntervention 2015; 11
Pilgrim Thomas, Jüni Peter, Wenaweser Peter, Blöchlinger Stefan, Nietlispach Fabian, Rigamonti Fabio, Taniwaki Masanori, Khattab Ahmed A, Jamshidi Peiman, Kaiser Christoph, Weilenmann Daniel, Cook Stéphane, Muller Olivier, Vuilliomenet André, Tüller David, Roffi Marco, Heg Dik, Piccolo Raffaele, Windecker Stephan
Improvement in left ventricular ejection fraction and reverse remodeling in elderly heart failure patients on intense NT-proBNP-guided therapy
Kaufmann B, Rocca H, Pfisterer M, Bernheim A, Nietlispach F, Bucher U, Maeder M, Min S, Goetschalckx K, TIME-CHF Investigators. Improvement in left ventricular ejection fraction and reverse remodeling in elderly heart failure patients on intense NT-proBNP-guided therapy. Int J Cardiol 2015; 191:286-93.
02.05.2015Improvement in left ventricular ejection fraction and reverse remodeling in elderly heart failure patients on intense NT-proBNP-guided therapy
02.05.2015Int J Cardiol 2015; 191:286-93
Kaufmann Beat A, Rocca Hans-Peter Brunner-La, Pfisterer Matthias E, Bernheim Alain M, Nietlispach Fabian, Bucher Urs, Maeder Micha, Min Son Y, Goetschalckx Kaatje, TIME-CHF Investigators
Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF
Sanders-van Wijk S, Brunner-La Rocca H, Pfisterer M, Peter M, Rickenbacher P, Erne P, Estlinbaum W, Rickli H, Nietlispach F, Maeder M, TIME-CHF Investigators. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF. Circ Heart Fail 2013; 7:131-9.
18.12.2013Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF
18.12.2013Circ Heart Fail 2013; 7:131-9
Sanders-van Wijk Sandra, Brunner-La Rocca Hans-Peter, Pfisterer Matthias P, Peter Martin, Rickenbacher Peter, Erne Paul, Estlinbaum Werner, Rickli Hans, Nietlispach Fabian, Maeder Micha, TIME-CHF Investigators
Frequency and predictors of hyperkalemia in patients ≥60 years of age with heart failure undergoing intense medical therapy
Muzzarelli S, Brunner-La Rocca H, Pfisterer M, Burkard T, Julius B, Nietlispach F, Rickli H, Toggweiler S, Maeder M, TIME-CHF Investigators. Frequency and predictors of hyperkalemia in patients ≥60 years of age with heart failure undergoing intense medical therapy. Am J Cardiol 2011; 109:693-8.
05.12.2011Frequency and predictors of hyperkalemia in patients ≥60 years of age with heart failure undergoing intense medical therapy
05.12.2011Am J Cardiol 2011; 109:693-8
Muzzarelli Stefano, Brunner-La Rocca Hans-Peter, Pfisterer Matthias Emil, Burkard Thilo, Julius Barbara, Nietlispach Fabian, Rickli Hans, Toggweiler Stefan, Maeder Micha, TIME-CHF Investigators